Free Trial

Mutual of America Capital Management LLC Has $11.12 Million Holdings in CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

Mutual of America Capital Management LLC lessened its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 2.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 41,908 shares of the financial services provider's stock after selling 1,262 shares during the quarter. Mutual of America Capital Management LLC's holdings in CME Group were worth $11,118,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in CME. Wayfinding Financial LLC acquired a new stake in shares of CME Group in the first quarter valued at about $25,000. Cornerstone Planning Group LLC grew its position in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after buying an additional 55 shares in the last quarter. New Age Alpha Advisors LLC grew its position in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after buying an additional 43 shares in the last quarter. Golden State Wealth Management LLC grew its position in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after buying an additional 98 shares in the last quarter. Finally, Alpine Bank Wealth Management acquired a new stake in CME Group during the first quarter worth about $32,000. Institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Royal Bank Of Canada reissued a "sector perform" rating and set a $269.00 target price on shares of CME Group in a research report on Thursday, April 3rd. Barclays lifted their target price on CME Group from $283.00 to $299.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 10th. Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Oppenheimer lifted their price objective on CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Finally, Piper Sandler lifted their price objective on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $261.80.

Get Our Latest Stock Report on CME Group

CME Group Trading Up 1.2%

CME stock traded up $3.21 during trading on Wednesday, hitting $278.21. The company had a trading volume of 1,262,174 shares, compared to its average volume of 2,173,449. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a 50-day moving average price of $276.31 and a 200-day moving average price of $259.92. CME Group Inc. has a 12 month low of $193.25 and a 12 month high of $290.79. The stock has a market cap of $100.25 billion, a price-to-earnings ratio of 28.04, a PEG ratio of 4.83 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The firm had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the previous year, the company posted $2.50 EPS. CME Group's revenue was up 10.4% on a year-over-year basis. As a group, analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.80%. The ex-dividend date was Monday, June 9th. CME Group's dividend payout ratio (DPR) is presently 50.30%.

Insider Activity at CME Group

In other CME Group news, Director Phyllis M. Lockett sold 1,060 shares of the company's stock in a transaction on Monday, May 19th. The shares were sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the sale, the director owned 3,108 shares in the company, valued at approximately $863,651.04. The trade was a 25.43% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Daniel G. Kaye sold 500 shares of the company's stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the sale, the director owned 3,668 shares of the company's stock, valued at $1,035,916.56. The trade was a 12.00% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,400 shares of company stock worth $3,680,610. 0.30% of the stock is owned by company insiders.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines